The deal – which was announced at DIA’s 49th annual meeting in Boston, US last week – will see Patient Reminder’s cloud-based system and messaging technologies offered to Ceduit’s clients either as a standalone service or integrated into its Interactive Response Technology (IRT) platform.
Cenduit says that techniques such as SMS, email, voicemail and iCal are a vital way increasing of increasing patient compliance and retention, claiming its use of text message in a recent trial increased retention rates by 40%.
CEO Jogin Desai said: “We are excited about making our first acquisition – the first of many steps we are taking to create happier sites. Happy sites are more productive and more profitable, and Cenduit sites are happier because we understand that technology is only part of the equation needed for their success.
“The other part is a thorough understanding – and response to patient and sponsor needs through continually evolving innovative products and services. Acquiring Patient Reminders is one more example of how Cenduit enables site efficiency and patient compliance for superior outcomes in current and future trials.”